Venlafaxine Hydrochloride
Product Images NDC 50090-5255

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-5255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine-01 (Ff9008be 0609 415c 810f C2bbbbdf305e 01)

A chart illustrating the pharmacokinetic (PK) fold change and 90% confidence interval (CI) of venlafaxine when coadministered with various interacting drugs. The chart compares changes in Cmax, AUC, and ODV parameters relative to a reference value and provides dosing recommendations such as 'Avoid concomitant use,' 'No dose adjustment,' and cautions for specific drugs.*

FDA Label Image

Venlafaxine-02 (Ff9008be 0609 415c 810f C2bbbbdf305e 02)

A scatter plot chart showing pharmacokinetic fold changes and 90% confidence intervals for various interacting drugs with Venlafaxine Hydrochloride. The chart lists interacting drugs, analytes, and provides recommendations on dose adjustment or clinical significance, plotted against the change relative to a reference value from 0 to 3.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-03 (Ff9008be 0609 415c 810f C2bbbbdf305e 03)

A dot plot chart showing pharmacokinetic changes of venlafaxine and its analyte in various special populations, including hepatic and renal impairment, CYP2D6 polymorphism, age over 60 years, and gender differences. The x-axis represents change relative to a reference value, indicating fold changes and 90% confidence intervals for parameters such as Cmax, AUC, and ODV. Recommendations for dose adjustments are also listed based on the population and PK changes.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-04 (Ff9008be 0609 415c 810f C2bbbbdf305e 04)

Chemical structure of venlafaxine hydrochloride showing its molecular arrangement including a methoxy-substituted aromatic ring, a cyclohexanol group, and a dimethylaminoethyl side chain, with HCl indicated as the hydrochloride salt form.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-14 (Ff9008be 0609 415c 810f C2bbbbdf305e 14)

Venlafaxine Hydrochloride 37.5 mg capsules bottle label by A-S Medication Solutions. The amber plastic bottle contains 100 capsules. The label includes directions for dispensing and administration, barcode, and storage information. The product NDC is 50090-5255.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-15 (Ff9008be 0609 415c 810f C2bbbbdf305e 15)

Venlafaxine Hydrochloride oral tablet white bottle with child-resistant cap from A-S Medication Solutions. The label includes proprietary name, directions, warnings, and dosage form details. The NDC 50090-5255 is visible on the label.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-16 (Ff9008be 0609 415c 810f C2bbbbdf305e 16)

Venlafaxine Hydrochloride tablet bottle label by A-S Medication Solutions. The amber plastic bottle shows a white label with black text including the proprietary name, and product details. The label includes directions and warnings typical for a prescription medication bottle.*

FDA Label Image

Label Image (Lbl500905255)

Packaging label of Venlafaxine Hydrochloride 150 mg extended-release capsules. The label includes the product NDC 50090-5255 from A-S Medication Solutions. The package contains 90 capsules and provides storage instructions to keep the product at 60 to 70 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.